These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17940502)

  • 1. Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.
    Gakiopoulou H; Korkolopoulou P; Levidou G; Thymara I; Saetta A; Piperi C; Givalos N; Vassilopoulos I; Ventouri K; Tsenga A; Bamias A; Dimopoulos MA; Agapitos E; Patsouris E
    Br J Cancer; 2007 Oct; 97(8):1124-34. PubMed ID: 17940502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication protein A in nonearly ovarian adenocarcinomas: correlation with MCM-2, MCM-5, Ki-67 index and prognostic significance.
    Levidou G; Ventouri K; Nonni A; Gakiopoulou H; Bamias A; Sotiropoulou M; Papaspirou I; Dimopoulos MA; Patsouris E; Korkolopoulou P
    Int J Gynecol Pathol; 2012 Jul; 31(4):319-27. PubMed ID: 22653344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of SIRT1 in ovarian epithelial tumours.
    Jang KY; Kim KS; Hwang SH; Kwon KS; Kim KR; Park HS; Park BH; Chung MJ; Kang MJ; Lee DG; Moon WS
    Pathology; 2009; 41(4):366-71. PubMed ID: 19404850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced retinoblastoma gene protein to Ki-67 ratio is an adverse prognostic indicator for ovarian adenocarcinoma patients.
    Konstantinidou AE; Korkolopoulou P; Vassilopoulos I; Tsenga A; Thymara I; Agapitos E; Patsouris E; Davaris P
    Gynecol Oncol; 2003 Mar; 88(3):369-78. PubMed ID: 12648589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas.
    Vassilopoulos I; Korkolopoulou P; Konstantinidou AE; Patsouris E; Eftichiadis C; Thymara I; Perdiki M; Pavlakis K; Agapitos E; Davaris PS
    Histol Histopathol; 2003 Jul; 18(3):761-70. PubMed ID: 12792888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.
    Giaginis C; Georgiadou M; Dimakopoulou K; Tsourouflis G; Gatzidou E; Kouraklis G; Theocharis S
    Dig Dis Sci; 2009 Feb; 54(2):282-91. PubMed ID: 18465232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
    Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
    Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
    Skirnisdottir I; Seidal T
    Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
    Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
    Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
    Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
    Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
    Costa MJ; Hansen CL; Walls JE; Scudder SA
    Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
    Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
    Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
    Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
    Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.